Relief Therapeutics Holding SA and NRx Pharmaceuticals, inc. further extend their stay of pending litigation to provide additional time for the parties to finalize their litigation settlement - Seite 2
RELIEF THERAPEUTICS Holding SA is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbols RLFTF and RLFTD. For more information, visit www.relieftherapeutics.com. Follow Relief on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause actual results in future periods to differ
materially from forecasted results. A number of factors, including (i) whether Relief and NRx will successfully complete their proposed litigation settlement, and (ii) those factors described in
Relief's filings with the SIX Stock Exchange and the U.S. Securities and Exchange Commission could adversely affect Relief. Copies of Relief's filings with the SEC are available on the
SEC EDGAR database at www.sec.gov. Relief does not undertake any obligation to update the information contained herein, which speaks only as of this date.
CONTACT:
RELIEF THERAPEUTICS Holding SA Jack Weinstein Chief Financial Officer and Treasurer contact@relieftherapeutics.com |
FOR MEDIA/INVESTOR INQUIRIES: LifeSci Advisors Irina Koffler (917) 734-7387 lkoffler@lifesciadvisors.com |
Lesen Sie auch
Additional features:
File: Ad hoc
End of Inside Information
Language: | English |
Company: | Relief Therapeutics Holding SA |
Avenue de Secheron 15 | |
1202 Geneva | |
Switzerland | |
Phone: | +41 22 545 11 16 |
E-mail: | contact@relieftherapeutics.com |
Internet: | https://relieftherapeutics.com |
ISIN: | CH0100191136 |
Valor: | 10019113 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1481205 |